Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores
Status:
Completed
Trial end date:
2018-06-24
Target enrollment:
Participant gender:
Summary
This is a phase II, prospective, randomized, double-blind, parallel group,
acyclovir-controlled clinical study to evaluate the safety, tolerability and preliminary
therapeutic efficacy of ZEP-3 ointment 1.0% for the treatment of cold sores (Herpes
labialis), following five consecutive treatment days with five times daily topical
administration.